These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1782355)

  • 21. Antinociceptive activity of [beta-methyl-2', 6'-dimethyltyrosine(1)]-substituted cyclic [D-Pen(2), D-Pen(5)]Enkephalin and [D-Ala(2),Asp(4)]Deltorphin analogs.
    Bilsky EJ; Qian X; Hruby VJ; Porreca F
    J Pharmacol Exp Ther; 2000 Apr; 293(1):151-8. PubMed ID: 10734164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective opioid dipeptides.
    Temussi PA; Salvadori S; Amodeo P; Bianchi C; Guerrini R; Tomatis R; Lazarus LH; Picone D; Tancredi T
    Biochem Biophys Res Commun; 1994 Feb; 198(3):933-9. PubMed ID: 8117299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Refinement of conformational preferences of Leu enkephalin and Tyr-Gly-Gly-Phe by 15N n.m.r.: chemical shifts and vicinal coupling constants.
    Garbay-Jaureguiberry C; Marion D; Fellion E; Roques BP
    Int J Pept Protein Res; 1982 Nov; 20(5):443-50. PubMed ID: 7174208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of conformational properties of linear and cyclic delta selective opioid ligands DTLET (Tyr-D X Thr-Gly-Phe-Leu-Thr) and DPLPE (Tyr-c[D X Pen-Gly-Phe-Pen]) by 1H n.m.r. spectroscopy.
    Belleney J; Roques BP; Fournie-Zaluski MC
    Int J Pept Protein Res; 1987 Sep; 30(3):356-64. PubMed ID: 3692682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
    Schmidt R; Wilkes BC; Chung NN; Lemieux C; Schiller PW
    Int J Pept Protein Res; 1996 Nov; 48(5):411-9. PubMed ID: 8956074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enkephalin analogues containing beta-naphthylalanine at the fourth position.
    Mierke DF; Said-Nejad OE; Schiller PW; Goodman M
    Biopolymers; 1990 Jan; 29(1):179-96. PubMed ID: 2158358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.
    Shook JE; Kazmierski W; Wire WS; Lemcke PK; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1018-25. PubMed ID: 2843623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligands.
    Kramer TH; Davis P; Hruby VJ; Burks TF; Porreca F
    J Pharmacol Exp Ther; 1993 Aug; 266(2):577-84. PubMed ID: 8394911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L; Lee NM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proposals for the mu-active conformation of the enkephalin analog Tyr-cyclol(-N gamma-D-A2-bu-Gly-Phe-Leu-).
    Maigret B; Fournie-Zaluski MC; Roques B; Premilat S
    Mol Pharmacol; 1986 Mar; 29(3):314-20. PubMed ID: 3005838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural studies of opioid peptides: a review of recent progress in x-ray diffraction studies.
    Deschamps JR; George C; Flippen-Anderson JL
    Biopolymers; 1996; 40(1):121-39. PubMed ID: 8541444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conformational analysis of the biologically active cyclic analog of beta-casomorphin H-Tyr-cyclo[D-OrnPheProGly].
    Kostetsky PV; Arkhipova SF
    Biochemistry (Mosc); 1999 Sep; 64(9):1005-11. PubMed ID: 10521717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
    Mitrovic I; Napier TC
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the substitution of Phe4 in the opioid peptide [D-Ala8]dynorphin A-(1-11)NH2.
    Vig BS; Zheng MQ; Murray TF; Aldrich JV
    J Med Chem; 2003 Sep; 46(19):4002-8. PubMed ID: 12954053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual effects of DAMGO [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin and CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2) on adenylyl cyclase activity: implications for mu-opioid receptor Gs coupling.
    Szücs M; Boda K; Gintzler AR
    J Pharmacol Exp Ther; 2004 Jul; 310(1):256-62. PubMed ID: 14996951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Folded conformations of the delta-selective opioid dermenkephalin with head-to-tail interactions. A simulated annealing study through NMR restraints.
    Naim M; Nicolas P; Baron D
    Int J Pept Protein Res; 1996 May; 47(5):353-60. PubMed ID: 8791158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conformation-activity relationships of cyclic dermorphin analogues.
    Wilkes BC; Schiller PW
    Biopolymers; 1990 Jan; 29(1):89-95. PubMed ID: 2158362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the bioactive form of linear peptide antagonists at the omega-opioid receptor.
    Chao TM; Perez JJ; Loew GH
    Biopolymers; 1996 Jun; 38(6):759-68. PubMed ID: 8652796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conformational-energy studies of tetrapeptide opiates. Candidate active and inactive conformations.
    Loew G; Hashimoto G; Williamson L; Burt S; Anderson W
    Mol Pharmacol; 1982 Nov; 22(3):667-77. PubMed ID: 7155126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conformational analysis of beta-methyl-para-nitrophenylalanine stereoisomers of cyclo[D-Pen2, D-Pen5]enkephalin by NMR spectroscopy and conformational energy calculations.
    Shenderovich MD; Kövér KE; Nikiforovich GV; Jiao D; Hruby VJ
    Biopolymers; 1996 Feb; 38(2):141-56. PubMed ID: 8589249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.